{"id":"W3202928000","doi":"10.1016/j.annonc.2021.08.1097","title":"584P Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant prostate cancer (mCRPC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Abiraterone acetate; Medicine; Prostate cancer; Prednisone; Enzalutamide; Androgen deprivation therapy; Oncology; Clinical endpoint; Internal medicine; Abiraterone; Acis; Antiandrogen; Quality of life (healthcare); Cancer; Clinical trial; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009521241,0.001207302,0.002057354,0.0004476091,0.0004582585,0.001096382,0.0008516224,0.0010549,0.006815157],"category_scores_gemma":[0.0008714981,0.000480226,0.002032263,0.0005650589,0.00106706,0.0007395289,0.0004311927,0.004432384,0.0009794958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007223506,"about_ca_system_score_gemma":0.001231048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001670748,"about_ca_topic_score_gemma":0.003250671,"domain_scores_codex":[0.9995384,0.0001987177,0.00002362795,0.00006671339,0.00005100052,0.000121624],"domain_scores_gemma":[0.999386,0.0001173788,0.00009561284,0.00004280003,0.00003545356,0.0003226232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9096542,0.01727405,0.002275246,0.0003980787,0.001114088,0.00006370225,0.00007471999,0.0009944724,0.006021831,0.0001712354,0.001246201,0.0607122],"study_design_scores_gemma":[0.706881,0.27643,0.01198075,0.00003861423,0.0007902972,0.0001352582,0.00005503241,0.0009743506,0.001224197,0.0002535292,0.001212002,0.00002494159],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939721,0.002092649,0.0001763759,0.0004510933,0.0001813624,0.0006383532,0.0006251601,0.00006724281,0.001795435],"genre_scores_gemma":[0.9940322,0.001420545,0.0005739754,0.0003442204,0.0002058891,0.0008691374,0.0009430839,0.00001466091,0.001596432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006815157,"threshold_uncertainty_score":0.02279902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1693330360404185,"score_gpt":0.4695793393923535,"score_spread":0.300246303351935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}